Matches in Wikidata for { <http://www.wikidata.org/entity/Q65403126> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q65403126 description "clinical trial" @default.
- Q65403126 description "ensayu clínicu" @default.
- Q65403126 description "klinisch onderzoek" @default.
- Q65403126 description "клінічне випробування" @default.
- Q65403126 name "BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment" @default.
- Q65403126 name "BI 655066 / ABBV-066" @default.
- Q65403126 type Item @default.
- Q65403126 label "BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment" @default.
- Q65403126 label "BI 655066 / ABBV-066" @default.
- Q65403126 prefLabel "BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment" @default.
- Q65403126 prefLabel "BI 655066 / ABBV-066" @default.
- Q65403126 P1050 Q65403126-02D4B5A2-C1FE-44FA-B7D7-6577E8825031 @default.
- Q65403126 P1132 Q65403126-270E9DEE-30D5-40B9-A232-B5326A67B99B @default.
- Q65403126 P1476 Q65403126-19139492-9B4B-4261-BD32-CC6E728FF523 @default.
- Q65403126 P2899 Q65403126-EEA490C4-69AE-4927-B402-C6847F8B21AD @default.
- Q65403126 P3098 Q65403126-42E5C5B5-B694-4555-8A64-C906DCB9C7A8 @default.
- Q65403126 P31 Q65403126-9F2ECF39-385B-4CAA-883C-025E97CD2AA3 @default.
- Q65403126 P580 Q65403126-EAB7A2B9-DB64-44EC-8504-6A8D8E715873 @default.
- Q65403126 P582 Q65403126-D34303EF-B119-4FA9-BA25-D6FB607D5AF0 @default.
- Q65403126 P6099 Q65403126-F9897767-4837-4AB6-A56D-01F55CEE3A57 @default.
- Q65403126 P8363 Q65403126-F87324AD-6BF7-4E1A-AC56-7992CB015929 @default.
- Q65403126 P1050 Q179945 @default.
- Q65403126 P1132 "+507" @default.
- Q65403126 P1476 "BI 655066 / ABBV-066 (Risankizumab) Versus Placebo In a Multicenter Randomized Double-blind Study in Patients With Moderate to Severe Chronic Plaque Psoriasis Evaluating the Efficacy and Safety With Randomized Withdrawal and Re-treatment (IMMhance)" @default.
- Q65403126 P2899 "+18" @default.
- Q65403126 P3098 "NCT02672852" @default.
- Q65403126 P31 Q30612 @default.
- Q65403126 P580 "2016-02-29T00:00:00Z" @default.
- Q65403126 P582 "2017-08-02T00:00:00Z" @default.
- Q65403126 P6099 Q42824827 @default.
- Q65403126 P8363 Q78089383 @default.